Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG, Mavroudi I, Pontikoglou C, Ximeri M, Stavroulaki E, Pyrovolaki K, Velegraki M, Spanoudakis M, Goulielmos G, Papadaki HA. Eliopoulos DG, et al. Among authors: spanoudakis m. Eur J Haematol. 2009 Dec 1;83(6):535-40. doi: 10.1111/j.1600-0609.2009.01319.x. Epub 2009 Jul 14. Eur J Haematol. 2009. PMID: 19614955
COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias.
Spanoudakis M, Yilmaz Karapinar D, Dale D, Bolyard AA, Tran E, Roganovic J, Bartels M, Kapor S, Guardo D, Yacobovich J, Nilsson C, Bezzerri V, Cipolli M, Pegoraro A, Aleksov E, Guenova M, Dufour C, Fioredda F, Papadaki HA, Palmblad J. Spanoudakis M, et al. Br J Haematol. 2024 Jun;204(6):2480-2483. doi: 10.1111/bjh.19411. Epub 2024 Mar 20. Br J Haematol. 2024. PMID: 38506338 No abstract available.
The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action.
Fioredda F, Skokowa J, Tamary H, Spanoudakis M, Farruggia P, Almeida A, Guardo D, Höglund P, Newburger PE, Palmblad J, Touw IP, Zeidler C, Warren AJ, Dale DC, Welte K, Dufour C, Papadaki HA. Fioredda F, et al. Among authors: spanoudakis m. Hemasphere. 2023 Mar 30;7(4):e872. doi: 10.1097/HS9.0000000000000872. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37008163 Free PMC article.
A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial.
Dennis M, Burnett A, Hills R, Thomas I, Ariti C, Severinsen MT, Hemmaway C, Greaves P, Clark RE, Copland M, Russell N; National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group. Dennis M, et al. Br J Haematol. 2021 Jul;194(2):298-308. doi: 10.1111/bjh.17501. Epub 2021 May 7. Br J Haematol. 2021. PMID: 33961292 Clinical Trial.
16 results